The willingness to pay for the coronavirus disease 2019 vaccine was about US$71 for a vaccine with 90% effectiveness, a risk of severe complications for 1 person per 1 million people, imported vaccine, and 24-month duration of protection attributes.Risk of severe side effects and efficacy were the strongest attributes of the public’s preferences for vaccine selection.Potential capacity to spread the virus in the community and employment in the healthcare sector were the strongest attributes of the public’s preferences for prioritizing individuals to get the vaccine.